2022 Corporate Partners
BioCryst is a biotech company committed to discovering novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist. We’re dedicated to delivering extraordinary medicines that empower patients to live ordinary lives.
Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing pharmaceutical therapies to prevent, manage, and treat food and metabolic-related diseases, including gastrointestinal conditions. Aimmune has one FDA, EU, UK and Swiss-approved medicine for peanut allergy and other investigational therapies in development. For more information, please visit www.aimmune.com.